Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 470
Immune Disorders Drugs 198
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 128
Drug Discovery 122
Central Nervous System Drugs 107
Endocrine and Metabolic Disorders Drugs 104
Clinical Trials 101
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 91
Leukemia Drugs 84
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 55
Brain Cancer Drugs 51
Skin Cancer Drugs 50
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 35
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 31
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 27
Analgesics 27
Drugs by Therapeutic Area 24
HIV/AIDS Drugs 23
Kidney Cancer Drugs 22
Antibiotics 22
Prostate Cancer Drugs 19
Colon Cancer Drugs 19
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Anti-Obesity Drugs 7
Cough and Cold Drugs 6
Company Reports 5
Anxiety Drugs 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,434 Results (Page 89 of 122)
- Relevance
  Sort by

Multiple Sclerosis Therapies Market Report by Drug, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033

 Report
August 2025
120 Pages
Global

From

€2268EUR$2,549USD£1,991GBP

€2668EUR$2,999USD£2,342GBP

Myositis - Pipeline Insight, 2025

 Drug Pipelines
April 2025
80 Pages
Global

From

€1424EUR$1,600USD£1,250GBP

€1779EUR$2,000USD£1,562GBP

Autoinjectors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
June 2025
180 Pages
Global

From

€4004EUR$4,500USD£3,514GBP

Autoimmune Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3995EUR$4,490USD£3,507GBP

Mucopolysaccharidosis Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3995EUR$4,490USD£3,507GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Crohn's Disease (CD) Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3995EUR$4,490USD£3,507GBP

Sporadic Inclusion Body Myositis (sIBM) - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1424EUR$1,600USD£1,250GBP

€1779EUR$2,000USD£1,562GBP

Chemokine Receptor Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
120 Pages
Global

From

€1424EUR$1,600USD£1,250GBP

€1779EUR$2,000USD£1,562GBP

Heart Failure Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
190 Pages
Global

From

€4004EUR$4,500USD£3,514GBP

Multiple Sclerosis Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029

 Report
February 2024
112 Pages
Global

From

€4226EUR$4,750USD£3,710GBP

Canada Anti-Hypertensive Drugs Market Competition Forecast & Opportunities, 2028

 Report
October 2023
84 Pages
Canada

From

€3114EUR$3,500USD£2,733GBP

Crohn's Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2135EUR$2,400USD£1,874GBP

€2669EUR$3,000USD£2,343GBP

Antidiabetics Market by Product Type, by Application, by Distribution channel, and By Region

 Report
March 2024
200 Pages
Global

From

€3692EUR$4,150USD£3,241GBP

Leukemia Therapeutics Market Size, Share & Industry Trends Analysis Report By Drug Class (Targeted Therapy & Immunotherapy and Chemotherapy), By Distribution Channel, By Type, By Regional Outlook and Forecast, 2023 - 2029

 Report
May 2023
236 Pages
Global

From

€3203EUR$3,600USD£2,812GBP

Next Generation Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
106 Pages
Global

€4444EUR$4,995USD£3,901GBP

Alpha Mannosidosis Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3995EUR$4,490USD£3,507GBP

Facial Palsy Market - Global Forecast 2025-2030

 Report
August 2025
195 Pages
Global

From

€3154EUR$3,545USD£2,769GBP

€3505EUR$3,939USD£3,076GBP

Multiple Sclerosis Market - Global Forecast 2025-2032

 Report
October 2025
185 Pages
Global

From

€3154EUR$3,545USD£2,769GBP

€3505EUR$3,939USD£3,076GBP

Parkinson's Disease Therapeutics Market - Global Forecast 2025-2030

 Report
October 2025
186 Pages
Global

From

€3154EUR$3,545USD£2,769GBP

€3505EUR$3,939USD£3,076GBP

Hormone Therapy Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3995EUR$4,490USD£3,507GBP

2,434 Results (Page 89 of 122)
- 1
- 87
- 88
- 89
- 90
- 91

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.